{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:29:56Z","timestamp":1782858596465,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T00:00:00Z","timestamp":1670112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T00:00:00Z","timestamp":1670112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University of Guadalajara - Strengthening Research and Postgraduate 2018","award":["number 244159"],"award-info":[{"award-number":["number 244159"]}]},{"name":"Universidad de Guadalajara through Fortalecimiento de la Investigaci\u00f3n y el Posgrado 2021"},{"name":"PRODEP- SEP Mexico","award":["UDG-PTC-1433"],"award-info":[{"award-number":["UDG-PTC-1433"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-022-00966-2","type":"journal-article","created":{"date-parts":[[2022,12,4]],"date-time":"2022-12-04T18:02:17Z","timestamp":1670176937000},"page":"1349-1357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TGFB1 mRNA expression and frequency of the\u2009+\u2009869T&gt;C and\u2009+\u2009915G&gt;C genetic variants: impact on risk for systemic sclerosis"],"prefix":"10.1007","volume":"23","author":[{"given":"Jos\u00e9 Alvaro","family":"Lomeli-Nieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Francisco","family":"Mu\u00f1oz-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Eduardo","family":"Navarro-Zarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Johana","family":"Ba\u00f1os-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Garc\u00eda-Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabell","family":"Alvarado-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Uriel","family":"Anaya-Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Oreg\u00f3n-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo","family":"Fuentes-Baez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isela","family":"Parra-Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Hern\u00e1ndez-Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,4]]},"reference":[{"key":"966_CR1","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s10067-019-04459-8","volume":"38","author":"CJ Ba\u00f1os-Hern\u00e1ndez","year":"2019","unstructured":"Ba\u00f1os-Hern\u00e1ndez CJ, Navarro-Zarza JE, Bucala R, et al. Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile. Clin Rheumatol. 2019;38:1643\u201354. https:\/\/doi.org\/10.1007\/s10067-019-04459-8.","journal-title":"Clin Rheumatol"},{"key":"966_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7861\/clinmedicine.16-1-55","volume":"16","author":"CP Denton","year":"2016","unstructured":"Denton CP. Advances in pathogenesis and treatment of systemic sclerosis. Clin Med. 2016;16:55\u201360. https:\/\/doi.org\/10.7861\/clinmedicine.16-1-55.","journal-title":"Clin Med"},{"key":"966_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s41232-021-00167-6","volume":"41","author":"Y Ota","year":"2021","unstructured":"Ota Y, Kuwana M. Updates on genetics in systemic sclerosis. Inflamm Regen. 2021;41:17. https:\/\/doi.org\/10.1186\/s41232-021-00167-6.","journal-title":"Inflamm Regen"},{"key":"966_CR4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","volume":"44","author":"FC Arnett","year":"2001","unstructured":"Arnett FC, Cho M, Chatterjee S, et al. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum. 2001;44:1359\u201362.","journal-title":"Arthritis Rheum"},{"key":"966_CR5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","volume":"41","author":"EP Stern","year":"2015","unstructured":"Stern EP, Denton CP. The pathogenesis of systemic sclerosis. Rheum Dis Clin North Am. 2015;41:367\u201382. https:\/\/doi.org\/10.1016\/j.rdc.2015.04.002.","journal-title":"Rheum Dis Clin North Am"},{"key":"966_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/BOR.0000000000000735","volume":"32","author":"C Orvain","year":"2020","unstructured":"Orvain C, Assassi S, Avouac J, Allanore Y. Systemic sclerosis pathogenesis: contribution of recent advances in genetics. Curr Opin Rheumatol. 2020;32:505\u201314. https:\/\/doi.org\/10.1097\/BOR.0000000000000735.","journal-title":"Curr Opin Rheumatol"},{"key":"966_CR7","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"NG Frangogiannis","year":"2020","unstructured":"Frangogiannis NG. Transforming growth factor\u2013\u03b2 in tissue fibrosis. J Exp Med. 2020;217:e20190103. https:\/\/doi.org\/10.1084\/jem.20190103.","journal-title":"J Exp Med"},{"key":"966_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.matbio.2017.12.016","volume":"68\u201369","author":"AH Gy\u00f6rfi","year":"2018","unstructured":"Gy\u00f6rfi AH, Matei A-E, Distler JHW. Targeting TGF-\u03b2 signaling for the treatment of fibrosis. Matrix Biol J Int Soc Matrix Biol. 2018;68\u201369:8\u201327. https:\/\/doi.org\/10.1016\/j.matbio.2017.12.016.","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"966_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/ard.53.11.763","volume":"53","author":"N Snowden","year":"1994","unstructured":"Snowden N, Coupes B, Herrick A, et al. Plasma TGF beta in systemic sclerosis: a cross-sectional study. Ann Rheum Dis. 1994;53:763\u20137. https:\/\/doi.org\/10.1136\/ard.53.11.763.","journal-title":"Ann Rheum Dis"},{"key":"966_CR10","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1093\/rheumatology\/kei088","volume":"44","author":"M Dziadzio","year":"2005","unstructured":"Dziadzio M, Smith RE, Abraham DJ, et al. Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score. Rheumatol Oxf Engl. 2005;44:1518\u201324. https:\/\/doi.org\/10.1093\/rheumatology\/kei088.","journal-title":"Rheumatol Oxf Engl"},{"key":"966_CR11","doi-asserted-by":"publisher","first-page":"6064830","DOI":"10.1155\/2016\/6064830","volume":"2016","author":"AT Dantas","year":"2016","unstructured":"Dantas AT, Gon\u00e7alves SMC, de Almeida AR, et al. Reassessing the role of the active TGF-\u03b21 as a biomarker in systemic sclerosis: association of serum levels with clinical manifestations. Dis Markers. 2016;2016:6064830. https:\/\/doi.org\/10.1155\/2016\/6064830.","journal-title":"Dis Markers"},{"key":"966_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00841-0","author":"JA Lomel\u00ed-Nieto","year":"2022","unstructured":"Lomel\u00ed-Nieto JA, Mu\u00f1oz-Valle JF, Ba\u00f1os-Hern\u00e1ndez CJ, et al. Transforming growth factor beta isoforms and TGF-\u03b2R1 and TGF-\u03b2R2 expression in systemic sclerosis patients. Clin Exp Med. 2022. https:\/\/doi.org\/10.1007\/s10238-022-00841-0.","journal-title":"Clin Exp Med"},{"key":"966_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/5584_2019_341","volume":"1153","author":"D Majewski","year":"2019","unstructured":"Majewski D, Majewska KA, Kuznar-Kaminska B, et al. Systemic sclerosis and serum content of transforming growth factor. Adv Exp Med Biol. 2019;1153:63\u20137. https:\/\/doi.org\/10.1007\/5584_2019_341.","journal-title":"Adv Exp Med Biol"},{"key":"966_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-2249.2004.02642.x","volume":"138","author":"E Scala","year":"2004","unstructured":"Scala E, Pallotta S, Frezzolini A, et al. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol. 2004;138:540\u20136. https:\/\/doi.org\/10.1111\/j.1365-2249.2004.02642.x.","journal-title":"Clin Exp Immunol"},{"key":"966_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/s0923-1811(01)00128-1","volume":"27","author":"S Sato","year":"2001","unstructured":"Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci. 2001;27:140\u20136. https:\/\/doi.org\/10.1016\/s0923-1811(01)00128-1.","journal-title":"J Dermatol Sci"},{"key":"966_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/art.22289","volume":"56","author":"CP Denton","year":"2007","unstructured":"Denton CP, Merkel PA, Furst DE, et al. Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I\/II trial of CAT-192. Arthritis Rheum. 2007;56:323\u201333. https:\/\/doi.org\/10.1002\/art.22289.","journal-title":"Arthritis Rheum"},{"key":"966_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1136\/ard.61.8.678","volume":"61","author":"A Crilly","year":"2002","unstructured":"Crilly A, Hamilton J, Clark CJ, et al. Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis. Ann Rheum Dis. 2002;61:678\u201381. https:\/\/doi.org\/10.1136\/ard.61.8.678.","journal-title":"Ann Rheum Dis"},{"key":"966_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1684\/ecn.2016.0382","volume":"27","author":"GC Martelossi Cebinelli","year":"2016","unstructured":"Martelossi Cebinelli GC, Paiva Trugilo K, Badar\u00f3 Garcia S, Braj\u00e3o de Oliveira K. TGF-\u03b21 functional polymorphisms: a review. Eur Cytokine Netw. 2016;27:81\u20139. https:\/\/doi.org\/10.1684\/ecn.2016.0382.","journal-title":"Eur Cytokine Netw"},{"key":"966_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00296-010-1624-x","volume":"32","author":"JF Mu\u00f1oz-Valle","year":"2012","unstructured":"Mu\u00f1oz-Valle JF, Torres-Carrillo NM, Guzm\u00e1n-Guzm\u00e1n IP, et al. The functional class evaluated in rheumatoid arthritis is associated with soluble TGF-\u03b21 serum levels but not with G915C (Arg25Pro) TGF-\u03b21 polymorphism. Rheumatol Int. 2012;32:367\u201372. https:\/\/doi.org\/10.1007\/s00296-010-1624-x.","journal-title":"Rheumatol Int"},{"key":"966_CR20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2147\/CCID.S281585","volume":"13","author":"BT Ahmed","year":"2020","unstructured":"Ahmed BT, Saeed MY, Noori SH, Amin DM. TGF-\u03b21 gene polymorphism and its correlation with serum level of TGF-\u03b21 in Psoriasis vulgaris among Iraqi people. Clin Cosmet Investig Dermatol. 2020;13:889\u201396. https:\/\/doi.org\/10.2147\/CCID.S281585.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"966_CR21","first-page":"3479","volume":"97","author":"M Suthanthiran","year":"2000","unstructured":"Suthanthiran M, Li B, Song JO, et al. Transforming growth factor-\u03b21 hyperexpression in African-American hypertensives: a novel mediator of hypertension and\/or target organ damage. Proc Natl Acad Sci U S A. 2000;97:3479\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"966_CR22","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1097\/00007890-199810270-00009","volume":"66","author":"MR Awad","year":"1998","unstructured":"Awad MR, El-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation. 1998;66:1014\u201320. https:\/\/doi.org\/10.1097\/00007890-199810270-00009.","journal-title":"Transplantation"},{"key":"966_CR23","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747\u201355. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424.","journal-title":"Ann Rheum Dis"},{"key":"966_CR24","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"SA Miller","year":"1988","unstructured":"Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215. https:\/\/doi.org\/10.1093\/nar\/16.3.1215.","journal-title":"Nucleic Acids Res"},{"key":"966_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.7555\/JBR.31.20170034","volume":"32","author":"NB Ayers","year":"2018","unstructured":"Ayers NB, Sun C-M, Chen S-Y. Transforming growth factor-\u03b2 signaling in systemic sclerosis. J Biomed Res. 2018;32:3\u201312. https:\/\/doi.org\/10.7555\/JBR.31.20170034.","journal-title":"J Biomed Res"},{"key":"966_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1046\/j.1365-2133.2002.04947.x","volume":"147","author":"T Ohtsuka","year":"2002","unstructured":"Ohtsuka T, Yamakage A, Yamazaki S. The polymorphism of transforming growth factor-beta1 gene in Japanese patients with systemic sclerosis. Br J Dermatol. 2002;147:458\u201363. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.04947.x.","journal-title":"Br J Dermatol"},{"key":"966_CR27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1002\/art.23836","volume":"59","author":"L Beretta","year":"2008","unstructured":"Beretta L, Cappiello F, Moore JH, et al. Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients. Arthritis Rheum. 2008;59:974\u201383. https:\/\/doi.org\/10.1002\/art.23836.","journal-title":"Arthritis Rheum"},{"key":"966_CR28","first-page":"1520","volume":"30","author":"Y Sugiura","year":"2003","unstructured":"Sugiura Y, Banno S, Matsumoto Y, et al. Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis. J Rheumatol. 2003;30:1520\u20133.","journal-title":"J Rheumatol"},{"key":"966_CR29","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/1529-0131(200005)43:5<1068::AID-ANR17>3.0.CO;2-G","volume":"43","author":"X Zhou","year":"2000","unstructured":"Zhou X, Tan FK, Stivers DN, Arnett FC. Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association. Arthritis Rheum. 2000;43:1068\u201373.","journal-title":"Arthritis Rheum"},{"key":"966_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/j.1399-0039.2004.00185.x","volume":"63","author":"EB Lee","year":"2004","unstructured":"Lee EB, Kim JY, Lee YJ, et al. Transforming growth factor-beta1 polymorphisms in Korean patients with systemic sclerosis. Tissue Antigens. 2004;63:491\u20135. https:\/\/doi.org\/10.1111\/j.1399-0039.2004.00185.x.","journal-title":"Tissue Antigens"},{"key":"966_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/cbf.1649","volume":"28","author":"U B\u00fcy\u00fck","year":"2010","unstructured":"B\u00fcy\u00fck U, Ates O, Dalyan L, et al. Analysis of transforming growth factor beta 1 (TGF-beta1) gene polymorphisms in Turkish patients with scleroderma. Cell Biochem Funct. 2010;28:274\u20137. https:\/\/doi.org\/10.1002\/cbf.1649.","journal-title":"Cell Biochem Funct"},{"key":"966_CR32","unstructured":"rs1800470 (SNP) - Population genetics - Homo_sapiens - Ensembl genome browser 104. http:\/\/www.ensembl.org\/Homo_sapiens\/Variation\/Population?db=core;r=19:41352516-41353516;v=rs1982073;vdb=variation;vf=202322800. Accessed 14 Sep 2021"},{"key":"966_CR33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.humimm.2019.05.015","volume":"81","author":"F Ju\u00e1rez-Nicol\u00e1s","year":"2020","unstructured":"Ju\u00e1rez-Nicol\u00e1s F, Barquera R, Mart\u00ednez-\u00c1lvarez JC, et al. Genetic diversity of HLA system in a population from Guerrero, Mexico. Hum Immunol. 2020;81:550\u20132. https:\/\/doi.org\/10.1016\/j.humimm.2019.05.015.","journal-title":"Hum Immunol"},{"key":"966_CR34","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s00296-013-2826-9","volume":"33","author":"Y Wan","year":"2013","unstructured":"Wan Y, Wang Y, Yan J, et al. The effect of TGF-\u03b21 polymorphism on systemic sclerosis: a systematic review and pooled analysis of available literature. Rheumatol Int. 2013;33:2859\u201365. https:\/\/doi.org\/10.1007\/s00296-013-2826-9.","journal-title":"Rheumatol Int"},{"key":"966_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/RRBC.S83483","volume":"6","author":"S Mitra","year":"2016","unstructured":"Mitra S, Ray SK, Banerjee R. Synonymous codons influencing gene expression in organisms. Res Rep Biochem. 2016;6:57\u201365. https:\/\/doi.org\/10.2147\/RRBC.S83483.","journal-title":"Res Rep Biochem"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00966-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-022-00966-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-022-00966-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T14:21:51Z","timestamp":1690813311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-022-00966-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,4]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1007\/s10238-022-00966-2","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,4]]},"assertion":[{"value":"17 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted without any commercial or financial relationships construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were following the ethical standards of the Local Bioethical Committee at the Hospital General de Chilpancingo \u2018\u2018Dr. Raymundo Abarca Alarc\u00f3n\u201d (CI\/317\/2016) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study. In this consent, the participants accepted to participate in the study and to publish their results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}